Showing 4661-4670 of 20465 results for "".
- Neurophet, VHIR Launch MS MRI Validation Study for AQUA MShttps://reachmd.com/news/neurophet-vhir-launch-ms-mri-validation-study-for-aqua-ms/2487214/Key Takeaways Neurophet and VHIR announced a joint research collaboration focused on validating Neurophet AQUA MS for MRI-based multiple sclerosis lesion detection. VHIR will provide de-identified MRI scans and expert lesion labels, and the work will t
- TG Therapeutics Details Planned BRIUMVI Presentations for CMSC 2026https://reachmd.com/news/tg-therapeutics-details-planned-briumvi-presentations-for-cmsc-2026/2487215/Key Takeaways TG Therapeutics presented new data on BRIUMVI (ublituximab-xiiy) at the American Academy of Neurology (AAN) 2026 annual meeting focused on relapsing multiple sclerosis (RMS). The presentations included findings from the ENABLE Phase 4 obs
- BGN4 Probiotic Trial Links Microbiome Shifts To Biomarker Changeshttps://reachmd.com/news/bgn4-probiotic-trial-links-microbiome-shifts-to-biomarker-changes/2487218/Key Takeaways BGN4 was not associated with significant changes in hs-CRP, BMI, or body fat percentage, but significant between-group differences were reported for zonulin, TNFα, and fasting insulin. Supplementation was associated with enrichment of Bac
- Sun Pharma Previews Long-Term UNLOXCYT Follow-Up at ASCO 2026https://reachmd.com/news/sun-pharma-previews-long-term-unloxcyt-follow-up-at-asco-2026/2487216/Key Takeaways: Sun Pharma will present long-term follow-up data from the pivotal trial of UNLOXCYT (cosibelimab-ipdl) at the 2026 ASCO Annual Meeting. The data focus on patients with metastatic or locally advanced cutaneous squamous cell carcinoma (cSC
- PRONTO Trial Finds Mortality Drop With Procalcitonin Plus NEWS2https://reachmd.com/news/pronto-trial-finds-mortality-drop-with-procalcitonin-plus-news2/2487230/Key Takeaways Twenty-eight-day mortality in patients with suspected sepsis was lower in the procalcitonin-guided group than in the usual-care group. Intravenous antibiotic initiation at 3 hours was similar in the two groups. In the
- S-SMARTS Technique Demonstrates Early Promise in Breast Reconstruction Studyhttps://reachmd.com/news/s-smarts-technique-demonstrates-early-promise-in-breast-reconstruction-study/2487205/Investigators from Osaka University reported favorable early oncologic and cosmetic outcomes with a novel breast-conserving surgery reconstruction approach known as S-SMARTS, according to a feasibility study published online ahead of print in
- MARS-ED Trial: Machine Learning Risk Stratification In The EDhttps://reachmd.com/news/mars-ed-trial-machine-learning-risk-stratification-in-the-ed/2487185/Key Takeaways Prognostic discrimination with RISKINDEX was at least as high as the clinician intuition questions and higher than the standard scores examined in this trial. Treatment plans changed in 1 of 644 intervention patients, and admission, lengt
- Abatacept Versus Hydroxychloroquine in Palindromic Rheumatism Trialhttps://reachmd.com/news/abatacept-versus-hydroxychloroquine-in-palindromic-rheumatism-trial/2487184/Key Takeaways Over 24 months, abatacept was associated with less progression to rheumatoid arthritis than hydroxychloroquine in this seropositive palindromic rheumatism cohort. Remission was more common and attack intensity was lower with abatacept, wh
- Ultrasound Detects Subclinical Joint and Nail Changes in Pediatric Psoriasishttps://reachmd.com/news/ultrasound-detects-subclinical-joint-and-nail-changes-in-pediatric-psoriasis/2487206/Musculoskeletal ultrasound may help identify early inflammatory changes in children with psoriasis before the onset of clinically apparent arthritis, according to findings from a pilot study evaluating joint, entheseal, and nail abnormalities in pediatric patients.
- Pasteurized Akkermansia Muciniphila MucT In Weight Loss Maintenancehttps://reachmd.com/news/pasteurized-akkermansia-muciniphila-muct-in-weight-loss-maintenance/2487191/Key Takeaways MucT was associated with less weight regain than placebo during the maintenance phase. Net weight loss from baseline to the end of maintenance was greater with MucT than with placebo. Initial Akkermansia spp. abundance was associ